Showing 1 - 7 results of 7 for search 'Bi-Cheng Wang', query time: 0.02s Refine Results
  1. 1
    Letter to the editor: effects of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer—a prospective observation study

    Letter to the editor: effects of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer—a prospective obse... by Bi-Cheng Wang

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al

    Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk e... by Bi-Cheng Wang

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Letter to the editor: safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria

    Letter to the editor: safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage... by Bi-Cheng Wang

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer

    Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer by Bi-Cheng Wang

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis

    Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis by Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, Chen Fu

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.

    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone. by Zhan-Jie Zhang, Liang-Liang Shi, Xiao-Hua Hong, Bo-Ya Xiao, Guo-He Lin, Quentin Liu, Bi-Cheng Wang

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Storage of the vital metal tungsten in a dominant SCFA-producing human gut microbe Eubacterium limosum and implications for other gut microbes

    Storage of the vital metal tungsten in a dominant SCFA-producing human gut microbe Eubacterium limosum and implications for other gut microbes by Nana Shao, Dayong Zhou, Gerrit J. Schut, Farris L. Poole, Sydney B. Coffey, Aaron P. Donaghy, Saisuki Putumbaka, Michael P. Thorgersen, Lirong Chen, John Rose, Bi-Cheng Wang, Michael W. W. Adams

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: